articleClinical and Molecular HepatologySep 19, 2022GOLD OA

Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach

University of Vermont · Stanford Medicine · +2 more institutions

PubMed
Indexed incrossrefdoajpubmed

Abstract

Methods

Prevalence data from 245 articles involving 2,699,627 persons were used with a hierarchical Bayesian approach to forecast the prevalence of NAFLD through 2040. Subgroup analyses were performed for age, gender, presence of metabolic syndrome, region, and smoking status. Sensitivity analysis was conducted for clinical setting and study quality.

Results

The forecasted 2040 prevalence was 55.7%, a three-fold increase since 1990 and a 43.2% increase from the 2020 prevalence of 38.9%. The estimated average yearly increase since 2020 was 2.16%. For those aged

Citation impact

300
total citations
FWCI
39.02
Percentile
100%
References
44
Citations per year

Authors

7

Topics & keywords

Keywords
  • Nonalcoholic fatty liver disease
  • Bayesian probability
  • Internal medicine
  • Fatty liver
  • Nonalcoholic steatohepatitis
  • Medicine
  • Liver disease
  • Gastroenterology
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding